News

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...
BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...
Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s successor is ongoing. Novo Nordisk says the leadership transition is “made in ...
Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.
The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.
FAMAR Group, a CDMO, has signed an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma.
Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...
What’s at stake in the face the enforcement deadlines and how exception management lays the groundwork for future-ready ...
Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...